References
- Elsherbiny A , DobrevaG. Epigenetic memory of cell fate commitment. Curr. Opin. Cell Biol.69, 80–87 (2021).
- D’Urso A , BricknerJH. Mechanisms of epigenetic memory. Trends Genet.30(6), 230–236 (2014).
- Loppin B , BergerF. Histone variants: the nexus of developmental decisions and epigenetic memory. Annu. Rev. Genet.54(1), 121–149 (2020).
- Kahney EW , RanjanR , GleasonRJ , ChenX. Symmetry from asymmetry or asymmetry from symmetry?Cold Spring Harb. Symp. Quant. Biol.82, 305–318 (2017).
- Idrissou M , SanchezA , Penault-LlorcaF , BignonYJ , Bernard-GallonD. Epi-drugs as triple-negative breast cancer treatment. Epigenomics12(8), 725–742 (2020).
- Revenko AS , KalashnikovaEV , GemoAT , ZouJX , ChenH-W. Chromatin loading of E2F-MLL complex by cancer-associated coregulator ANCCA via reading a specific histone mark. Mol. Cell. Biol.30(22), 5260–5272 (2010).
- Jacques C , LavaudM , GeorgesSet al. BET bromodomains’ functions in bone-related pathologies. Epigenomics12(2), 127–144 (2020).
- Fu J , ZhangJ , ChenXet al. ATPase family AAA domain-containing protein 2 (ATAD2): from an epigenetic modulator to cancer therapeutic target. Theranostics13(2), 787–809 (2023).
- Xie D , PeiQ , LiJ , WanX , YeT. Emerging role of E2F family in cancer stem cells. Front. Oncol.11, 723137 (2021).
- Liu ZL , BiXW , LiuPPet al. Expressions and prognostic values of the E2F transcription factors in human breast carcinoma. Cancer Manag. Res.10, 3521–3532 (2018).
- Muhammad A , ForcadosGE , KatsayalBSet al. Potential epigenetic modifications implicated in triple- to quadruple-negative breast cancer transition: a review. Epigenomics14(11), 711–726 (2022).
- Kalashnikova EV , RevenkoAS , GemoATet al. ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2. Cancer Res.70(22), 9402–9412 (2010).
- Duan Z , AndrewsNP , ChenCZet al. Targeting bromodomain protein ANCCA/ATAD2 enhances the efficacy of DNA-damaging chemotherapy agents and radiation. Oncol. Rep.43(1), 318–327 (2020).
- Vacek J , HrbacJ. Sensors and microarrays in protein biomarker monitoring: an electrochemical perspective spots. Bioanalysis12(18), 1337–1345 (2020).
- VanArsdale E , PitzerJ , WangSet al. Enhanced electrochemical measurement of β-galactosidase activity in whole cells by coexpression of lactose permease, LacY. BioTechniques73(5), 233–237 (2022).
- Teixeira SR , AbreuCM , ParkesLet al. Direct monitoring of breast and endometrial cancer cell epigenetic response to DNA methyltransferase and histone deacetylase inhibitors. Biosens. Bioelectron.141, 111386 (2019).
- Scholz BA , Millán-AriñoL , GöndörA. 3D Nuclear architecture and epigenetic memories: regulators of phenotypic plasticity in development, aging and cancer. In:Chromatin Regulation and DynamicsGöndörA ( Ed.) Academic Press, Inc., London, UK, 417–460 (2017).